Scientists have discovered a new mutation in the COL7A1 gene — which provides instructions for making a type of…
Articles by Iqra Mumal, MSc
Topical treatment with B-VEC, formerly known as KB103, is safe and leads to complete and durable wound healing in…
An experimental cell therapy where a patient’s own skin cells (fibroblasts) are engineered in the lab to carry a healthy…
RegeneRx Biopharmaceuticals announced a clinical trial update on RGN-137, an investigational therapy for the treatment of epidermolysis bullosa…
Fibrocell Science has completed a type C meeting with the U.S. Food and Drug Administration in which they discussed the…
New York-based EB Research Partnership (EBRP), along with the EB Research Foundation in Australia, announced a global collaboration that aims to…
Allogeneic fibroblast injections are an effective and safe treatment strategy for non-healing wounds in patients with recessive dystrophic epidermolysis…
Epidermolysis bullosa (EB) can affect the gastrointestinal tract, leading to the development of esophageal stenosis, or a narrowing of the…
Patients with epidermolysis bullosa acquisita sometimes can develop acute renal failure, according to a case report. The report, “…
A protein called SYK is a major regulator of the inflammatory response carried out by myeloid cells in mouse models…
Japanese physicians have reported a newly discovered mutation in the COL7A1 gene, called c.6885_6898del14, which resulted in the development of…
A case report demonstrates that a novel mutation discovered in the junctional plakoglobin (JUP) gene can lead to lethal congenital…